TACTI-004 planned ~756 patients across >150 sites and enrolled 378 by February 2026, including squamous and nonsquamous NSCLC irrespective of PD-L1 status. Randomization compared eftilagimod alfa plus ...
Abstract: In traditional Chinese medicine, deciphering herb-symptom associations (HSAs) and revealing their mechanisms of action are crucial for bridging traditional knowledge and modern biomedicine.
The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...
Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...
Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd ...
Abstract: Human action recognition is a cornerstone of computer vision, with applications spanning from smart surveillance systems to assistive technologies. This survey paper provides a structured ...
A new study reveals how the Alzheimer’s drug lecanemab mobilizes the brain’s immune cells to remove toxic amyloid plaques. By identifying the antibody’s Fc fragment as the crucial trigger for ...
2Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results